Using machine learning and a large volume of data on genes and existing drugs, researchers at Lund University in Sweden have ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope to ovarian cancer patients who do not respond to existing treatments.

Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude Children's Research Hospital scientists. Many diseases, including cancers, ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...

Scientists have identified a potential new treatment strategy for Alzheimer’s disease using a combination of two existing cancer drugs. The research suggests that targeting multiple types of brain ...

Researchers at the University of Michigan have identified a novel way to counter drug resistance in KRAS-mutant non-small ...

BioNTech’s oncology strategy centers on a bispecific antibody that the company envisions as the backbone of many potential drug combinations for many types of cancer. Bristol Myer Squibb is buying ...

A study comparing the gene expression signature of Alzheimer's disease with those elicited by 1,300 approved drugs found a combination of two cancer medications that could treat the most common form ...

(L) First and co-corresponding author Charlie Wright, PhD, St. and (R) co-corresponding author Paul Geeleher, PhD, both of the St. Jude Department of Computational Biology. (MEMPHIS, Tenn. – December ...